Selank: The Complete Guide

Selank occupies a genuinely unusual position in the modern peptide landscape. Most compounds discussed in wellness and research circles are either experimental and lightly studied, or well-studied but heavily restricted. Selank is one of the few that has actually completed clinical trials — in Russia, where it has been approved as a prescription anxiolytic medication since the early 2000s. Outside of Russia, it remains unapproved and is sold as a research compound, which is the framework we operate within in Costa Rica.

This guide gives you a clear, honest picture of what Selank actually is, how it works, what the published research shows, and what you should know if you are considering it. If you are still working through whether Selank or a different peptide fits your goals, our choosing your first peptide guide may help orient you first.

What Is Selank?

Selank is a synthetic heptapeptide — a chain of seven amino acids with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. Its full chemical designation is TP-7 (tuftsin-proline-glycine-proline).

It was developed at the Institute of Molecular Genetics of the Russian Academy of Sciences and the V.V. Zakusov Institute of Pharmacology starting in the 1980s and 1990s. The goal was to create a stable, centrally active peptide capable of modulating anxiety and cognition through a different mechanism than the benzodiazepines and SSRIs that dominate Western anxiety treatment.

Its Origin in the Immune System

Selank's story actually begins with the immune system, not the brain. The first four amino acids of Selank (Thr-Lys-Pro-Arg) are identical to tuftsin, a naturally occurring tetrapeptide produced when the body enzymatically cleaves immunoglobulin G (IgG). Tuftsin is part of your innate immune response and helps regulate immune cell activity.

The Russian researchers added a three-amino-acid extension (Pro-Gly-Pro) to the natural tuftsin sequence. This modification accomplished two things: it dramatically improved the peptide's metabolic stability (extending its half-life from minutes to hours), and it shifted the biological activity from primarily immune-modulating to primarily neuromodulatory. The result is a compound that retains some immune effects but produces meaningful effects on anxiety and cognition.

The Regulatory Picture

Selank was formally approved by the Russian Federal Supervision Agency for Use of Healthcare as a treatment for generalized anxiety disorder and neurasthenia. It is sold in Russia under the brand name Selanc. This makes Selank unusual among research peptides — most have not undergone formal clinical approval anywhere in the world.

Outside Russia, however, Selank has not been approved by the FDA, EMA, or Costa Rica's Ministerio de Salud as a finished pharmaceutical drug. In every market outside Russia (including ours), it is sold as a research compound for laboratory and scientific study. This is the standard framework for most peptides in our product catalog.

How Selank Works

Selank does not work like a benzodiazepine, an SSRI, or any other Western anxiety medication. It acts through several interconnected pathways simultaneously, which is part of why its effects look so different from conventional anxiolytics in research.

This multi-target profile is one of the most distinctive things about Selank. Most psychoactive medications work through a single receptor or transporter — SSRIs block serotonin reuptake, benzodiazepines bind GABA-A receptors, and so on. Selank touches several pathways at once, which appears to produce a more balanced effect with fewer of the side effects associated with single-target drugs.

What Makes Selank Different

If you are familiar with conventional anxiety medications, the most striking thing about Selank is what it does not do.

Anxiolytic Without Sedation

The defining feature of Selank in research literature is anxiolysis without sedation. Most compounds that meaningfully reduce anxiety — benzodiazepines, alcohol, certain antihistamines — produce significant drowsiness as part of their mechanism. Russian clinical trials comparing Selank to benzodiazepines reported comparable anxiolytic efficacy without the cognitive impairment, sleepiness, or motor effects that limit benzodiazepine use to evenings or weekends for most people. This is one of the main reasons Selank attracts interest from researchers studying daytime-functional anxiety reduction.

No Reported Dependence or Withdrawal

Benzodiazepines produce physical dependence with regular use, and abrupt discontinuation can cause severe withdrawal symptoms including rebound anxiety, insomnia, and seizures. SSRIs produce a different dependence pattern — not addictive, but discontinuation often causes weeks of difficult symptoms. Selank, in Russian clinical research, has not shown either pattern. Subjects discontinuing it after weeks of regular use have not reported the rebound or withdrawal seen with conventional anxiolytics.

Cognitive Enhancement Profile

Unlike most anxiolytics, which can impair cognitive function and short-term memory, Selank appears to enhance them. Published research has documented improvements in attention, short-term memory, and cognitive flexibility in both anxious and healthy subjects. This combination — reducing anxiety while improving cognition — is unusual among compounds in this category.

Low Toxicity Profile

Animal toxicology studies have not been able to establish a clear lethal dose for Selank, even at doses many times the therapeutic range. Doses up to 500 times the typical therapeutic level have been investigated without acute toxicity. This is one of the most favorable acute safety profiles of any peptide in the cognitive category.

What the Research Shows

Selank's research base is more developed than most peptides we discuss, but it has a specific shape worth understanding.

Russian Clinical Trials

Selank has been studied in actual human clinical trials in Russia, which led to its formal approval as a prescription anxiolytic. These trials examined Selank in patients with generalized anxiety disorder (GAD) and neurasthenia (a condition involving fatigue, mental exhaustion, and irritability). Key findings included:

• Anxiolytic efficacy comparable to benzodiazepines in head-to-head trials
• Significantly less sedation and cognitive impairment than benzodiazepines
• No measurable dependence or withdrawal upon discontinuation
• Documented improvements in attention and short-term memory
• Favorable tolerability across the populations studied

Preclinical Research

A larger body of animal and cellular research has documented Selank's effects on stress response systems, BDNF expression, enkephalin metabolism, and immune function. Notable findings include neuroprotective effects in models of ethanol-induced memory impairment, anxiolytic effects in primate stress models, and modulation of cytokine profiles in immune research.

Western Research Limitations

The honest gap in the literature: large-scale, multicenter randomized controlled trials conducted under Western regulatory standards have not been published. Most Selank research originates from Russian academic institutions, and while the methodology in many of these studies is sound, the body of evidence outside Russia is smaller than what regulatory bodies like the FDA typically require for drug approval. This is part of why Selank remains unapproved outside Russia despite its evidence base.

Common Research Applications

Based on the published research and reported community use, Selank is most commonly explored in the following contexts.

Anxiety Research

This is Selank's most established application. Research has documented reduction in generalized anxiety, performance anxiety, and stress-related symptoms — typically without the sedation that limits benzodiazepine use. Users often describe a calming effect that does not interfere with daytime function.

Cognitive Enhancement

Improvements in focus, attention, and short-term memory have been documented in both anxious and healthy subjects. Researchers and community users sometimes use Selank before cognitively demanding tasks, learning sessions, or work requiring sustained focus.

Stress Resilience

Through its effects on enkephalin metabolism and stress-response neuropeptides, Selank is studied for its potential to support resilience to chronic stress. This is distinct from its acute anxiolytic effects — it relates more to long-term stress adaptation.

Mood Support

Modulation of serotonergic and dopaminergic systems contributes to mood-stabilizing effects in research. Selank has been examined in models of mild depression and irritability, though it is not positioned in the literature as a direct antidepressant.

Immune Modulation

The tuftsin heritage means Selank retains some immunomodulatory activity. Research has examined its effects on T-cell function, natural killer cell activity, and inflammatory cytokine production. This is a secondary application but worth knowing about.

Withdrawal Support

Some animal research has explored Selank's potential to ease withdrawal symptoms from alcohol and opioids, mediated partly through its enkephalin-stabilizing effects. This remains preclinical and is not a primary research focus.

Dosing & Administration

Selank can be administered through two main routes: subcutaneous injection or intranasal spray. Each has practical advantages, and the appropriate dose varies between routes because of differences in bioavailability.

Subcutaneous Injection

Subcutaneous injection delivers Selank into the fatty tissue beneath the skin, where it absorbs gradually into the bloodstream. This is the more common route for research-grade Selank and is what our 10 mg vial is designed for.

Intranasal Administration

Intranasal Selank is administered as a nasal spray and is absorbed through the nasal mucosa directly into the bloodstream, with some research suggesting more direct delivery to the brain. The bioavailability is lower than subcutaneous injection, so doses are higher to achieve comparable effects.

Reconstitution Math (10 mg Vial)

The standard recommendation for our 10 mg Selank vial is to reconstitute with 2 ml of bacteriostatic water, giving a final concentration of 5 mg/ml (5,000 mcg/ml). At that concentration, each unit on a standard U-100 insulin syringe equals 50 mcg of Selank — so a 150 mcg dose is 3 units, and a 300 mcg dose is 6 units. For complete step-by-step reconstitution and dosing instructions, see our how to reconstitute peptides and dosing and injection basics guides.

Cycling Considerations

While Selank has not shown the dependence pattern of conventional anxiolytics, most research community protocols still recommend cycling — typically 10 to 14 days on, followed by a 1 to 3 week rest period. This precaution exists because long-term continuous use has not been well-studied, and cycling reduces any potential for receptor desensitization. Russian clinical use has often been continuous over longer periods, but the conservative approach for research use is cycling.

Safety & Side Effects

Selank has one of the most favorable side effect profiles of any psychoactive compound in research. That said, no biologically active substance is completely free of effects, and there are still things worth knowing.

Most Commonly Reported Side Effects

• Mild injection site reactions (redness, minor irritation) — rotating sites minimizes this
• Occasional mild nasal irritation with intranasal use
• Headache, infrequently reported, usually mild and resolving within a day or two
• Very rare: mild dizziness or lightheadedness, particularly with higher intranasal doses

Notably absent from the side effect literature: sedation, motor impairment, cognitive dulling, dependence, withdrawal upon stopping, or sexual side effects. This is what makes Selank stand out compared to most compounds in the anxiety category.

What We Don't Yet Know

The limitations of the safety picture come from the limited research base outside Russia:

• Long-term safety beyond the durations studied (months rather than years)
• Drug interactions with most Western prescription medications
• Effects in specific populations (pregnant women, young people, those with serious mental health conditions)
• Theoretical concerns around long-term GABAergic system effects with extended continuous use

Who Should Be Cautious

• Anyone taking benzodiazepines, SSRIs, MAO inhibitors, or other psychiatric medications — without consulting a qualified healthcare professional first
• Pregnant or breastfeeding women (no safety data)
• Anyone with a serious mental health condition, especially if currently in treatment
• Anyone with active autoimmune disease (given Selank's immunomodulatory effects)
• People who have had adverse reactions to other peptides previously

Selank vs Other Options

If you are weighing Selank against other approaches to anxiety, cognition, or sleep, here is how it compares to the most common alternatives.

Selank is rarely the best choice for someone with severe clinical anxiety or major depression — those conditions usually warrant the evidence base of approved medications under medical supervision. Selank fits best for researchers and community users with mild-to-moderate anxiety, daytime stress, or cognitive demands where a non-sedating anxiolytic profile is valuable.

Important Considerations Before Buying

Quality Matters

Because Selank is sold as a research compound rather than an approved medication in most markets, supplier quality varies. A reputable supplier will provide a Certificate of Analysis (COA) showing third-party purity testing — ours are available on request for every product. Read about how we approach quality.

Storage Discipline

Lyophilized Selank vials should be refrigerated. Once reconstituted with bacteriostatic water, the solution should remain refrigerated at 2 to 8 degrees Celsius and used within approximately 28 days. In Costa Rica's tropical climate, storage discipline matters more than in cooler regions — power outages, warm kitchens, and frequent fridge openings can shorten peptide shelf life.

Realistic Expectations

Selank is not a magic solution. Most users in research and community reports describe it as a noticeable but subtle effect — reduced anxiety, smoother thinking, calmer reactions to stress. If you are expecting dramatic transformation, you may be disappointed. If you are expecting a more even baseline and improved cognitive performance under stress, you are more likely to find what you are looking for.

Have a Healthcare Conversation

This is especially important if you currently take any psychiatric medications, have a diagnosed mental health condition, or are managing chronic stress as part of a broader treatment plan. Selank's effects on GABAergic, serotonergic, and dopaminergic systems mean interactions with other compounds touching those pathways are theoretically possible.

How We Sell Selank in Costa Rica

We carry Selank in a 10 mg lyophilized (freeze-dried) vial — the standard research-grade format. Every product is stored in climate-controlled conditions before shipping, which matters more in our market than in cooler ones.

What You'll Need

• The 10 mg Selank vial
• Bacteriostatic water in 2 ml or 3 ml size for reconstitution
• Insulin syringes (U-100, 29 to 31 gauge, 1/2 inch needle) — available at any local farmacia
• Alcohol swabs (70% isopropyl prep pads)
• A sharps container for safe needle disposal

Bulk Discount

Five or more vials of the same product earns a 15% discount automatically. For Selank specifically, this is most useful for users planning multiple cycles or stacking with other cognitive peptides over an extended period. Contact us with any bulk-order questions.

Local Sourcing Advantage

Buying Selank from a Costa Rica supplier eliminates the customs delays and cold-chain risks that come with international orders. We confirm stock with you before payment so you never pay for something that isn't available, and we answer every customer message personally.

Common Questions About Selank

Important disclaimer: The information in this guide is general educational content only. It is not medical advice, a prescription, or a personalized recommendation. Selank is not approved by the FDA, EMA, or Costa Rica's Ministerio de Salud as a finished pharmaceutical drug for human use. It is approved as a prescription medication in Russia but is sold elsewhere — including in Costa Rica — as a research compound intended for laboratory and scientific study. Dosing ranges discussed reflect what is commonly cited in published research and community use; they are not endorsements of those doses for any specific individual. Always consult a qualified healthcare professional before beginning any peptide protocol, especially if you take psychiatric medications or have any mental health condition. Products sold by Peptides Costa Rica are intended for laboratory and research purposes only.